Dr. Raphael Bueno | Mesothelioma Specialist in Boston, Massachusetts

Mesothelioma Clinical doctors

Dr. BuenoBoston, MA

Seventy five Francis StreetBoston, Mama 02115(617) 732-8148

Harvard Clinical Staff – 1985

Brigham and Women’s Wellbeing focus – 1993

Massachusetts Add up to Wellbeing focus – 1995

Overview/Scholastic Background

Dr. Raphael Bueno is the Boss, Division of Thoracic Careful activity and Bad habit Seat of Careful task for Most malignant growths and Translational Investigation at Boston’s Brigham and Women’s Wellbeing focus, an educating subsidiary of the Harvard College Staff of Cure the assemble Dr. Bueno in addition fills in as Educator of Careful task. As a 1985 alumni of Harvard Clinical Staff, Dr. Bueno played out a residency program at Brigham and Women’s Wellbeing focus and a partnership in Thoracic Careful activity on the Massachusetts Add up to Wellbeing center.

Board authorized in 1993, Dr. Bueno spent forceful of his initial calling teaching on the Harvard Clinical Personnel all around the 1990’s. Striking of Dr. Bueno’s additional most recent center has been treating sufferers of dangerous mesothelioma and lung most malignancies at heaps of stages. Dr. Bueno has considered broadly the propensities for all types of mesothelioma (counting peritoneal mesothelioma and pericardial mesothelioma) at a cell degree bearing in mind the end goal of coordinating his rising learning of cell-degree propensities into additional forceful and incredible mesothelioma treatment regimens.

Legit Features/Logical StudiesDr. Bueno’s present research activities envelop the examination of new focuses for lung most diseases and mesothelioma treatments, as successfully in light of the fact that the methodology of evaluations went for recognizing most tumors and distinguishing the anticipation of sufferers with thoracic malignancies following surgery. He’s the lead specialist of heaps of continuous clinical preliminaries, one of which is investigating biomarker reactions in tumor tissue in careful sufferers with harmful pleural mesothelioma.

Dr. Bueno serves these days as Program and Study Executive of the Overall Mesothelioma Program (Demon) at Brigham and Women’s Wellbeing focus/Harvard Clinical Personnel—essentially the fundamental program of its frame on the earth that turned out to be once essentially based with the mission of giving sufferers threatening pleural mesothelioma fundamentally the most present day and advanced treatment regimens accessible in the market. Amazing of Dr. Bueno’s exploration has been imprinted in across the country clinical diaries, including the Diary of Thoracic Cardiovascular Careful task. Among the issues investigated in his productions are the atomic pathways and restorative focuses in lung most tumors, chemotherapeutic medication opposition in essential dangerous pleural mesothelioma, and quality articulation proportion testing concentrated on the characterization of since quite a while ago settled lung versus lung tumors. U.S. News and World Archive has reasonable of late commended Dr. Bueno’s exploration in their specialist rankings. Sufferers with harmful mesothelioma are importuned to investigate if Dr. Bueno’s aptitudes in the field may probably well be gainful to them.

Publications

Shtivelman E, Hensing T, Simon GR, Dennis Dad, Otterson GA, Bueno R, Salgia R. Sub-atomic pathways and restorative focuses in lung generally tumors. Oncotarget. 2014 Blemish 21.

Mohiuddin Great acceptable, Haneuse S, Sofer T, Gill R, Jaklitsch MT, Colson YL, Small J, Bueno R, Mentzer SJ, Sugarbaker DJ, Swanson SJ. Connection between edge separation and local repeat among sufferers present process wedge resection for little (≤2 cm) non-little cell lung generally malignant growths. J Thorac Cardiovasc Surg. 2014 Apr;147(four):1169-Seventy five; discourse 1175-7.

Opitz I, Bueno R, Lim E, Walk H, Pastorino U, Boeri M, Rocco G, Biomolecular and clinical get ready in dangerous pleural mesothelioma and lung most malignant growths: what thoracic specialists may apparently well perhaps additionally unexcited know. European Diary Of Cardio Thoracic Careful task : Authentic Diary Of The European Alliance For Cardio Thoracic Careful activity. 2014 Blemish 12.

De Rienzo A, Yeap BY, Cibas ES, Richards WG, Dong L, Gill RR, Sugarbaker DJ, Bueno R. Quality articulation proportion test separates since quite a while ago settled lung from lung tumors in staunch tissue and FNA biopsies. J Mol Diagn. 2014 Mar;sixteen(2):267-Seventy two.

Chirieac LR, Barletta JA, Yeap BY, Richards WG, Tilleman T, Bueno R, Baldini EH, Godleski J, Sugarbaker DJ. Clinicopathologic qualities of threatening mesotheliomas coming up in sufferers with a background marked by radiation for Hodgkin and non-Hodgkin lymphoma. J Clin Oncol. 2013 Dec 20;31(36):4544-9.

De Rienzo A, Richards WG, Yeap BY, Coleman MH, Sugarbaker PE, Chirieac LR, Wang YE, Quackenbush J, Jensen RV, Bueno R. Successive Parallel Quality Proportion Tests Characterize Another Sub-atomic Demonstrative Strategy for Harmful Pleural Mesothelioma. Clin Most malignant growths Res. 2013 Apr 18.

Lee MS, Mamon HJ, Hong TS, Choi NC, Fidias PM, Kwak EL, Meyerhardt JA, Ryan DP, Bueno R, Donahue DM, Jaklitsch MT, Lanuti M, Rattner DW, Fuchs CS, Enzinger PC. Preoperative cetuximab, irinotecan, Cisplatin, and radiation treatment for sufferers with in the area advanced esophageal generally malignant growths. Oncologist. 2013;18(3):281-7.

Sugarbaker DJ, Gill RR, Yeap BY, Wolf AS, DaSilva MC, Baldini EH, Bueno R, Richards WG. Hyperthermic intraoperative pleural cisplatin chemotherapy stretches out interim to repeat and survival among low-chance sufferers with threatening pleural mesothelioma present process careful plainly visible aggregate resection. J Thorac Cardiovasc Surg. 2013 Apr;145(four):955-sixty three.

Rusch V, Baldini EH, Bueno R, De Perrot M, Flores R, Hasegawa S, Klepetko W, Krug L, Lang-Lazdunski L, Walk H, Weder W, Sugarbaker DJ, The job of careful cytoreduction in the treatment of threatening pleural mesothelioma: get together rundown of the Overall Mesothelioma Interest People group Congress, eleventh of September-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg. 2013 Apr;145(four):909-10.

Barbone D, Cheung P, Battula S, Busacca S, Dim SG, Longley DB, Bueno R, Sugarbaker DJ, Fennell DA, Broaddus VC. Vorinostat disposes of multicellular obstruction of mesothelioma 3D spheroids by the exhaust of rebuilding of Noxa articulation. PLoS ONE. 2012;7(12):e52753.

Sugarbaker DJ, Wolf AS, Chirieac LR, Godleski JJ, Tilleman TR, Jaklitsch MT, Bueno R, Richards WG. Logical and obsessive parts of three-year overcomers of threatening pleural mesothelioma following extrapleural pneumonectomy. European Diary Of Cardio Thoracic Careful activity : Genuine Diary Of The European Association For Cardio Thoracic Careful task. 2011 Feb Eight.

Ou WB, Hubert C, Corson JM, Bueno R, Flynn DL, Sugarbaker DJ, Fletcher JA. Focused hindrance of numerous receptor tyrosine kinases in mesothelioma. Neoplasia. 2011 Jan;thirteen(1):12-22.

De Rienzo A, Dong L, Yeap BY, Jensen RV, Richards WG, Gordon GJ, Sugarbaker DJ, Bueno R. Rich needle goal biopsies for quality articulation proportion essentially based absolutely symptomatic and prognostic evaluations in threatening pleural mesothelioma. Clin Most malignant growths Res. 2011 Jan 15;17(2):310-6.

Sources

mesothelioma
mesothelioma

No Comments

Write a Reply or Comment

Your email address will not be published. Required fields are marked *


This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: